Seroprevalence of Hepatitis C virus-specific antibodies in a hospital based population attending tertiary care center: A study from Northern Telangana, India
Journal Title: Perspectives In Medical Research - Year 2018, Vol 6, Issue 2
Abstract
Bakground: Hepatitis C virus (HCV) infection is a bloodborne infection, most commonly transmitted through sharing of needles (unsafe injection practices), blood and blood products whereas sexual and vertical routes of transmission are less common. HCV causes silent acute infection to severe chronic infection manifesting as chronic liver disease, fibrosis, cirrhosis, cancer, and liver failure. However chronic HCV infection-related complications can be prevented by early screening and treatment if required. Objective : To evaluate the seroprevalence of HCV-specific antibodies in a hospital-based population. Materials and Methods :The present hospital record-based, a cross sectional study was carried out at the rural based tertiary care center, in Northern Telangana, India, from January 2017 to July 2017. A total of 3748 blood samples were screened for HCV-specific antibody using 4th generation HCV TRI-DOT (Diagnostic Enterprises, H.P. India). The data of those, who were found to be reactive for HCV-specific antibodies were statistically analyzed by chi-square test, and results were considered significant if the p value was <0.05. Results :Out of 3748 blood samples tested, 7 (0.19%) were found to be reactive for the HCV-specific antibody which includes 5 (0.23%) males and 2 (0.12%) females. The most commonly affected age group was less than 10 years. Conclusion : In this study, the seroprevalence of HCV-specific antibody was 0.19%. This study highlights the current prevalence rate of HCV infection at our tertiary care center recommending mandatory screening of hospital attending population for early detection and prevention of chronic HCV infection related complications.
Authors and Affiliations
Padmavali N Palange
Keywords
Related Articles
- EP ID EP304988
- DOI -
- Views 122
- Downloads 0
Drugs approved by Usfda in 2016
Adjunctive therapy in the treatment of partial-onset seizures in patients 16 years of age and older with epilepsy.
Outcome of (Philos) plate Osteosynthesis in the management of 3-part and 4-part proximal Humerus fractures in adults
Background: Even though the proximal humerus fracture are second most common fractures in upper extremity after distal radius treatment of these displaced 3-part & 4-part fractures is still challenging because of comminu...
Pulmonary Alveolar Microlithiais
Pulmonary Alveolar Microlithiasis (PAM) is a rare, slowly progressive lung disease, characterised by widespread intra-alveolar accumulation of minute calculi called microliths. It is caused by mutation in SCL34A2 gene en...
Percutaneous nephrolithotomy in the supine position: Initial experience at Yashoda Hospital
Objectives: To assess the feasibility of performing percutaneous nephrolithotomy (PCNL) with the patient supine. Although PCNL with the patient prone is the standard technique for treating large (>2 cm) renal stones incl...
Evaluation of effect of tobacco smoking on Absolute eosinophil count and Peak expiratory flow rate in male volunteers
Introduction: Tobacco smoking in India has been increasing alarmingly. Smoking is a known risk factor for chronic obstructive pulmonary disease, cardiovascular diseases and certain cancers, especially, the lung cancer....